United States Antimony Corporation (UAMY) Stock Price & Analysis
United States Antimony Corporation (UAMY) closed at USD 3.1 on Thursday, October 22, 2026, down 5.78% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 3.29; the Oct 22, 2026 session ranged USD 3.04–3.21 on volume of 5,898,339 shares. Market capitalization is $463.98M, with a 52-week range of USD 2.64–12.64 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 12:54 UTC.
Also available as compact Markdown for AI agents: nexqual.com/UAMY.md
Key facts (UAMY)
- Last four reported quarters (through Jun 30, 2026): revenue $36.4M, net income -$16.3M (-44.6% margin), free cash flow -$71.3M (SEC filings).
- Insider open-market purchases, last ~7 months: 5 Form 4 filings, $392K; 1 by opportunistic insiders, 0 by routine insiders.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (4 analysts), mean target USD 10.92 (range 9.25–13.5).
- Total return with dividends: 1Y -73.6% vs S&P 500 +14.9%; 5Y +269.1% vs S&P 500 +80.3%.
- Next earnings: 2026-11-16, EPS estimate USD -0.02, revenue estimate $16.7M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (UAMY)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $7.7M | $11.0M | $8.7M | $14.9M | $39.3M | $36.4M |
| Gross profit | $839K | $2.0M | -$3.3M | $3.5M | $9.9M | — |
| Operating income | -$660K | $348K | -$7.1M | -$2.4M | -$8.5M | -$23.3M |
| Net income | -$60K | $429K | -$6.3M | -$1.7M | -$4.3M | -$16.3M |
| EPS (diluted) | — | — | -$0.06 | -$0.02 | -$0.04 | — |
| Free cash flow | -$3.1M | -$2.0M | -$6.3M | $1.8M | -$37.5M | -$71.3M |
| Gross margin | 10.8% | 18.1% | -38.5% | 23.2% | 25.2% | — |
| Operating margin | -8.5% | 3.2% | -81.3% | -16.0% | -21.5% | -64.0% |
| Net margin | -0.8% | 3.9% | -73.0% | -11.6% | -11.1% | -44.6% |
| Revenue growth | +48.0% | +42.6% | -21.3% | +71.8% | +162.8% | — |
| Cash + short-term investments | $21.4M | $19.1M | $18.1M | — | — | — |
| Total debt | $228K | $312K | $28K | $328K | $195K | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (UAMY)
P/S 12.7x · EV/Sales 11.6x · P/B 2.6x · FCF yield -15.36% · Earnings yield -3.50% · Net cash $41.9M · EV $422M
Insider purchases (SEC Form 4, open-market, last ~7 months) (UAMY)
5 purchases, $392K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-09-01 | Bardswich Lloyd | Dir, EVP & Chief Mining Eng | 20,000 | $93K | 4.63 | Too little history (no open-market trades in 2024 or 2025) |
| 2026-09-01 | Carrabba Joseph A | Director | 21,300 | $101K | 4.72 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-31 | Aguirre Blaise A. | Director | 1,400 | $7K | 5.04 | Too little history (no open-market trades in 2023–2025) |
| 2026-08-28 | Evans Gary C | Chairman & CEO | 20,000 | $98K | 4.92 | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-15 | Marinelli Jon R | Director | 12,500 | $93K | 7.45 | Too little history (no open-market trades in 2023–2025) |
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (UAMY)
Consensus Buy (mean 2.00 on a 1–5 scale), 4 analysts; mean target USD 10.92 (low 9.25, high 13.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-12 | HC Wainwright & Co. | Target lowered | Buy | $11.75 → $9.25 |
Total return (dividends reinvested) (UAMY)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -73.6% | +269.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -73.7% | +29.8% |
| Volatility (annualized) | 119.2% | 96.4% |
| Max drawdown | -78.0% (May 2026→Oct 2026) | -76.7% (Oct 2025→Oct 2026) |
UAMY revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Antimony | $6.1M | 76.5% | -37.1% |
| Zeolite | $1.9M | 23.5% | +109.5% |
| Total revenue | $7.9M | 100% | — |
UAMY revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Antimony | $5.9M | 74.0% | -39.1% |
| Zeolite | $1.9M | 23.5% | +109.5% |
| Precious Metals | $196,980 | 2.5% | — |
| Total revenue | $7.9M | 100% | — |
UAMY revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| United States | $7.6M | 95.5% | -26.8% |
| Canada | $354,228 | 4.5% | +96.6% |
| Total revenue | $7.9M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
UAMY suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | Mexico | “The Company contracted with new ore suppliers in 2025 to provide antimony ore to our Madero facility in Mexico.” |
Quoted from the company's 10-K filed Mar 19, 2026.
UAMY company outlook (results filed Aug 17, 2026)
- “The increase primarily reflects higher non-cash share-based compensation expense, increased salaries and employee benefits associated with the company's expanded leadership team and operational infrastructure to match the growth projections we have in the back half of the year into 2027 and higher professional fees supporting several growth initiatives.”
- “Based on our current production and delivery schedule, we anticipate completing our first delivery order of $9.9 million nearly one year ahead of schedule.”
- “We expect to deliver our third and fourth truckloads of antimony ingots next week, which are anticipated to generate an additional $2.6 million in revenue for the third quarter.”
- “In addition, the company is currently testing truckloads five, six, and seven of antimony ingots totaling more than 120,000 pounds for anticipated shipment in the next few weeks.”
Quoted word-for-word from the SEC 8-K results press release.
UAMY analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.01 | $0.03 | -150.0% | $16.7M | 2 |
| Next quarter (ends Dec 2026) | $0.01 | $0.06 | -83.3% | $34.0M | 2 |
| Current fiscal year (ends Dec 2026) | $-0.07 | $0.10 | -177.2% | $64.9M | 3 |
| Next fiscal year (ends Dec 2027) | $0.10 | $0.34 | -69.1% | $201.8M | 2 |
UAMY options: expected move
Options price a move of about ±20.7% (±$0.65) by Nov 20, 2026, which includes earnings on Nov 16, 2026; the earnings reaction alone is priced at about ±3.6%. Over the last 8 reports the stock moved ±12.8% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Oct 30, 2026 | 7 | 90.4% | ±11.1% |
| Nov 6, 2026 | 14 | 87.1% | ±14.3% |
| Nov 13, 2026 | 21 | 93.7% | ±18.3% |
| Nov 20, 2026 | 28 | 92.9% | ±20.7% |
| Nov 27, 2026 | 35 | 94.5% | ±23.1% |
| Dec 4, 2026 | 42 | 94.8% | ±25.5% |
| Dec 18, 2026 | 56 | 84.0% | ±29.5% |
| Jan 15, 2027 | 84 | 90.5% | ±35.0% |
30-day implied volatility 89.5% vs 65.3% realized over the last 30 trading days. Put/call ratio (volume) 0.11. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 12:54 UTC)
| Price | USD 3.1 |
|---|---|
| Change | ▼ 5.78% (down) |
| Previous Close | USD 3.29 |
| Open | USD 3.15 |
| Day Range | USD 3.04 – 3.21 |
| 52-Week Range | USD 2.64 – 12.64 |
| Volume | 5,898,339 shares |
| Market Cap | $463.98M |
| Exchange | NYQ |
Technical Analysis (UAMY)
Nexqual's technical model rates UAMY "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 12:54 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 30.24 (neutral) |
| vs SMA50 | Below (USD 4.47) |
| MACD | -0.45 (negative) |
Analyst Ratings (UAMY)
Wall Street analysts rate UAMY "Buy" based on 4 analysts, with a mean price target of USD 10.92 (range USD 9.25–13.5), per Nexqual as of October 23, 2026 at 12:54 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 10.92 |
| High Target | USD 13.5 |
| Low Target | USD 9.25 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (UAMY)
| Next Earnings Date | 2026-11-16 |
|---|---|
| EPS Estimate | USD -0.02 |
| Revenue Estimate | $16.72M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0 vs est -0.02 ▲ beat |
| 2026-03-31 | USD -0.08 vs est -0.02 ▼ miss |
| 2025-12-31 | USD -0.01 vs est 0 ▼ miss |
| 2025-09-30 | USD -0.04 vs est 0.02 ▼ miss |
Source: Nexqual, October 23, 2026 at 12:54 UTC.
Financials & Fundamentals (UAMY)
| Total Revenue | $36.44M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -24.70% |
| Gross Margin | +17.44% |
| Operating Margin | -88.08% |
| Profit Margin | -44.60% |
| ROE | -14.87% |
| Debt / Equity | 0 |
| Current Ratio | 11.54 |
| Total Cash | $46.10M |
| Total Debt | $364,081 |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$71.28M (-195.6% of revenue) |
Source: Nexqual, October 23, 2026 at 12:54 UTC.
Financial Health Score (UAMY)
Nexqual rates United States Antimony Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 12:54 UTC.
| Growth | Strong — Revenue +163% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $42M cash and investments, no debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$71M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -15%, ROA -12.5% |
Ownership (UAMY)
| Insider Ownership | +8.54% |
|---|---|
| Institutional Ownership | +63.64% |
| Shares Outstanding | 149.67M |
| Float | 131.97M |
| Short % of Float | +26.11% |
Source: Nexqual, October 23, 2026 at 12:54 UTC.
Leadership (UAMY)
United States Antimony Corporation is led by Gary C. Evans, CEO & Chairman, per Nexqual as of October 23, 2026 at 12:54 UTC.
| CEO & Chairman | Gary C. Evans |
|---|---|
| Executive VP, Chief Mining Engineer & Director | Lloyd Joseph Bardswich P.Eng. |
| Senior VP & CFO | Shawn P. Winkler |
| President of Antimony Division | John C. Gustavsen |
| Vice President of Antimony Division | Aaron Tenesch |
Major Backers & Investors (UAMY)
Notable institutional backers of United States Antimony Corporation include Price (T.Rowe) Associates Inc, Van Eck Associates Corporation, VanEck ETF Trust-VanEck Rare Earth and Strategic Metals ETF, according to Nexqual as of October 23, 2026 at 12:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Price (T.Rowe) Associates Inc | 6.7% |
| Van Eck Associates Corporation | 5.72% |
| VanEck ETF Trust-VanEck Rare Earth and Strategic Metals ETF | 3.28% |
| Frontier Capital Management Company LLC | 2.87% |
| TR PRICE-Price (T.Rowe) Real Assets Trust I | 2.43% |
| T. Rowe Price | 2.37% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.58% |
| State Street | 7.58% |
| Vanguard Group | 3.69% |
| Geode Capital | 2.19% |
Source: Nexqual, October 23, 2026 at 12:54 UTC.
From United States Antimony Corporation's Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- While still procuring antimony ore from foreign suppliers, the Company's operation in Montana is once again vertically integrated with the mining of its own ore in 2025.
- Our zeolite segment includes our vertically integrated Bear River Zeolite ("BRZ") facility located in Preston, Idaho that mines, processes, and sells zeolite.
Partnerships
- In November 2025, the Company executed a five-year sales agreement with a new industrial customer for the sale of antimony trioxide.
- The Company is in the process of formalizing a definitive agreement with this third party to support further development of these relationships.
Legal & Regulatory Risks (Item 1A, quoted)
- We may be unable to comply with NYSE continued listing standards and our common stock may be delisted from the NYSE, which would likely cause the liquidity and market price of the common stock to decline.
- Our operations are subject to complex, evolving and increasingly stringent environmental laws and regulations. Compliance with environmental regulations, and litigation based on such regulations, involves significant costs and can threaten existing operations or constrain expansion opportunities.
- Laws in the U.S. such as CERCLA and similar state laws may expose us to joint and several liability or claims for contribution made by the government (state or federal) or private parties.
- The laws and regulations, changes in such laws and regulations, and lawsuits and enforcement actions described in this risk factor could lead to the imposition of substantial fines, remediation costs, penalties and other civil and criminal sanctions against us.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NEXA | Nexa Resources S.A. | USD 11.16 | ▼ 7.77% |
| SSMR | Sunshine Silver Mining & Refini | USD 13.17 | ▼ 0.83% |
| ALM | Almonty Industries Inc. | USD 8.75 | ▼ 6.32% |
| USAR | USA Rare Earth, Inc. | USD 9.63 | ▼ 5.87% |
| SKE | Skeena Resources Limited | USD 28.74 | ▼ 9.25% |
| MTRN | Materion Corporation | USD 219.12 | ▼ 12.43% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 12:54 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt